Literature DB >> 8825177

Immunological and virological markers of HIV-disease progression.

J M Zeller1, N L McCain, B Swanson.   

Abstract

This review, based upon scientific literature, evaluates a number of immunological and virological markers for their usefulness as prognostic indicators for progression of HIV disease. The most widely studied marker, the CD4 positive T lymphocyte count, is perhaps the best single indicator of stage of illness. Serum factors such as neopterin and beta-2 microglobulin, alone and in combination with CD4 cell counts, have been shown to have good predictive value. Measurement of viral burden by quantification of viral RNA levels in plasma and immune cells also holds promise for following disease progression. It is recommended that a combination of these factors be monitored in evaluating stage of illness and responses to therapy in HIV-infected persons.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8825177     DOI: 10.1016/S1055-3290(96)80034-3

Source DB:  PubMed          Journal:  J Assoc Nurses AIDS Care        ISSN: 1055-3290            Impact factor:   1.354


  8 in total

1.  Variations in serum IL-7 and 90K/Mac-2 binding protein (Mac-2 BP) levels analysed in cohorts of HIV-1 patients and correlated with clinical changes following antiretroviral therapy.

Authors:  E C Darcissac; V Vidal; X De La Tribonniere; Y Mouton; G M Bahr
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

2.  MicroRNAs and exosomes: key players in HIV pathogenesis.

Authors:  J Sadri Nahand; F Bokharaei-Salim; M Karimzadeh; M Moghoofei; S Karampoor; H R Mirzaei; A Tabibzadeh; A Jafari; A Ghaderi; Z Asemi; H Mirzaei; M R Hamblin
Journal:  HIV Med       Date:  2019-11-22       Impact factor: 3.180

3.  Naïve CD4+ cell counts significantly decay and high HIV RNA levels contribute to immunological progression in long-term non-progressors infected with HIV by blood products: a cohort study.

Authors:  Ling Xu; Yubin Liu; Xiaojing Song; Yanling Li; Yang Han; Ting Zhu; Wei Cao; Taisheng Li
Journal:  BMC Immunol       Date:  2021-06-03       Impact factor: 3.615

4.  Current status of medication adherence and infant follow up in the prevention of mother to child HIV transmission programme in Addis Ababa: a cohort study.

Authors:  Alemnesh H Mirkuzie; Sven Gudmund Hinderaker; Mitike Molla Sisay; Karen Marie Moland; Odd Mørkve
Journal:  J Int AIDS Soc       Date:  2011-10-21       Impact factor: 5.396

5.  MicroRNA Profile in CD8+ T-Lymphocytes from HIV-Infected Individuals: Relationship with Antiviral Immune Response and Disease Progression.

Authors:  Lander Egaña-Gorroño; Alberto C Guardo; Manel E Bargalló; Evarist Planet; Elisenda Vilaplana; Tuixent Escribà; Iñaki Pérez; Josep Maria Gatell; Felipe García; Mireia Arnedo; Montserrat Plana M
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

6.  HIV Progression Depends on Codon and Amino Acid Usage Profile of Envelope Protein and Associated Host-Genetic Influence.

Authors:  Ayan Roy; Rachana Banerjee; Surajit Basak
Journal:  Front Microbiol       Date:  2017-06-15       Impact factor: 5.640

7.  Low level expression of the Mitochondrial Antiviral Signaling protein (MAVS) associated with long-term nonprogression in SIV-infected rhesus macaques.

Authors:  Miaomiao Zhang; Zhuotao Fu; Jiantao Chen; Boqiang Zhu; Ye Cheng; Linchun Fu
Journal:  Virol J       Date:  2018-10-16       Impact factor: 4.099

8.  Long term non-progressor (LTNP) HIV infection.

Authors:  Praveen Kumar
Journal:  Indian J Med Res       Date:  2013-09       Impact factor: 2.375

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.